Venous Thromboembolism in Pediatric Vascular Anomalies

Area of Science:

• Vascular biology and medicine
• Pediatric hematology
• Thrombosis research

Background:

• Vascular anomalies involve abnormal development of blood and lymphatic vessels, often leading to dilated and misshapen structures.
• These anomalies disrupt normal fluid flow, increasing the risk of intralesional thrombosis and localized intravascular coagulopathy.
• Mechanisms involving abnormal endothelial and lymphoendothelial cells activate hemostasis and hyperfibrinolytic pathways, contributing to coagulopathy.

Purpose of the Study:

• To review the current understanding of thrombosis in pediatric vascular anomalies.
• To highlight the clinical impact and challenges in managing these conditions.
• To discuss recent advancements in imaging, treatment, and supportive care.

Main Methods:

• Literature review focusing on thrombosis associated with pediatric vascular anomalies.
• Analysis of the pathophysiology linking vascular malformations to prothrombotic activity.
• Synthesis of current approaches in diagnosis, intervention, and management.

Main Results:

• Vascular malformations, tumors, and syndromes exhibit varying prothrombotic activity and consumptive coagulopathy.
• Clinical impact ranges from quality-of-life issues to life-threatening embolic events.
• Limited literature exists on the study and treatment of thrombosis in pediatric vascular anomalies.

Conclusions:

• Despite limited research, significant progress has been made in imaging complex lesions and interventional therapies.
• Enhanced supportive care, including patient education, compression therapy, and anticoagulation, plays a vital role.
• Further research is needed to fully understand and effectively treat thrombosis in pediatric vascular anomalies.